Brought to you by 
Endo pays $190mm to acquire Somerset Therapeutics and manufacturing affiliate Wintac; terminated
28 Feb 2019
Executive Summary
Endo International PLC will pay $190mm to acquire privately held Somerset Therapeutics LLC, a US-based firm that develops and sells ophthalmic treatments and sterile injectables. The acquisition also includes the entire business of Somerset’s Wintac Ltd. contract development and manufacturing affiliate, located in India.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Endo pays $190mm to acquire Somerset Therapeutics and manufacturing affiliate Wintac; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice